(OCGN) Ocugen - Performance -44% in 12m
OCGN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
7.68%
#28 in Peer-Group
Rel. Strength
10.74%
#6851 in Stock-Universe
Total Return 12m
-44.04%
#126 in Peer-Group
Total Return 5y
337.19%
#4 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 15.2 |
| High / Low | USD |
|---|---|
| 52 Week High | 1.95 USD |
| 52 Week Low | 0.52 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 41.60 |
| Buy/Sell Signal +-5 | 0.97 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: OCGN (-44%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: OCGN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for OCGN
| Total Return (including Dividends) | OCGN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 7.87% | 3.36% | 5.25% |
| 3 Months | 44.56% | 15.73% | 24.13% |
| 12 Months | -44.04% | -7.02% | 14.15% |
| 5 Years | 337.19% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | OCGN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -41.1% | 4.4% | 81% |
| 3 Months | 88.7% | 78.8% | 96.9% |
| 12 Months | -65.7% | -85.8% | 44.9% |
| 5 Years | -32.3% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th71.50 | 4.37% | 2.49% |
| 3 Month | %th73.50 | 24.91% | 16.46% |
| 12 Month | %th38.00 | -39.81% | -50.97% |
| 5 Years | %th99.00 | 476.84% | 106.38% |
FAQs
Does Ocugen (OCGN) outperform the market?
No,
over the last 12 months OCGN made -44.04%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months OCGN made 44.56%, while XBI made 15.73%.
Performance Comparison OCGN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
OCGN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.5% | 2.6% | 0.7% | -58% |
| US NASDAQ 100 | QQQ | -4.2% | 2.6% | 0.1% | -57% |
| German DAX 40 | DAX | -2.3% | 9.3% | -11.4% | -73% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.3% | 4.6% | -2.7% | -64% |
| Hongkong Hang Seng | HSI | -4.1% | 1.8% | -18.7% | -83% |
| India NIFTY 50 | INDA | -2.6% | 4.4% | 0.4% | -43% |
| Brasil Bovespa | EWZ | -6.9% | -0.9% | -24.3% | -54% |
OCGN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.1% | 2% | -3.4% | -69% |
| Consumer Discretionary | XLY | -4% | 4.7% | 8.4% | -62% |
| Consumer Staples | XLP | -4.8% | 7.2% | -0.9% | -53% |
| Energy | XLE | -4.8% | 0.8% | 4.8% | -44% |
| Financial | XLF | -5.2% | 2.8% | -4.2% | -74% |
| Health Care | XLV | -3.9% | 5.7% | 8.1% | -39% |
| Industrial | XLI | -4.5% | 3.7% | -7.1% | -69% |
| Materials | XLB | -6.7% | 3.6% | -3.8% | -50% |
| Real Estate | XLRE | -4.4% | 6.9% | 1% | -57% |
| Technology | XLK | -5.2% | -0.8% | -1.6% | -55% |
| Utilities | XLU | -3.4% | 6.1% | -2.5% | -67% |
| Aerospace & Defense | XAR | -2.3% | 0.8% | -17.9% | -93% |
| Biotech | XBI | -5.4% | 4.5% | 13.9% | -37% |
| Homebuilder | XHB | -7% | 0.9% | 7.9% | -50% |
| Retail | XRT | -7% | 2.9% | 5% | -55% |
OCGN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -5.4% | -0.57% | 9.11% | -37% |
| Natural Gas | UNG | 5.1% | 17.7% | 17.5% | -42% |
| Gold | GLD | -4.7% | 9.1% | -19.9% | -83% |
| Silver | SLV | -5.5% | 1% | -16.6% | -62% |
| Copper | CPER | -3.5% | 3.3% | -16.4% | -55% |
OCGN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -2.6% | 6.8% | 4.1% | -42% |
| iShares High Yield Corp. Bond | HYG | -3.3% | 6.3% | 1.8% | -54% |